Moderna, Inc. (MRNA) Stock Analysis

Moderna, Inc. (MRNA) Stock Analysis — AI Research | MarketCI

MRNA

Market Closed

Moderna, Inc.

NASDAQHealthcare Biotechnology

5.80K employees

CEO: Stéphane Bancel

Founded: 2018

$63.96

+$0.00(+NaN%)

Market Cap

25.38B

Beta

1.03

52W Range

N/A

Dividend Yield

0.00%

Overview Forecasts Fundamental Market Sentiment Valuation Ownership

MRNA Price Chart

Historical price performance

Loading MCI price data...

MarketCI Investment Signals

AI-synthesized investment signal for MRNA built from valuation, fundamentals, sentiment, and risk models

Investment Signal

Strong Sell

Pass %

42.86%

Score

3/7

Fair Value Estimate

Cash flow analysis • Multiple methods

-$1.60

AI Price Target

Machine learning • Price prediction

$62.51

Market Sentiment

News & social media analysis

0.07

Value Investor Price

Classic value analysis

$0.00

Financial Health

Bankruptcy risk assessment

3.52

Quality Score

Financial strength rating

1.00

AI Investment Grade

Deep analysis of filings & news

75.00

Key Investment Highlights

Important factors affecting MRNA investment thesis

Due Diligence Analysis

Investment criteria assessment and scoring

Overall Assessment

46.15% Poor

Conditions Met

18.00/39.00

Due Diligence Score

46.15%

Due Diligence Conditions

Investment analysis conditions and results


	Fail
	Pass
	Fail
	Pass
	Fail
	Pass

Showing 1 to 6 of 46 conditions